Therapeutics: Nuclear receptor coactivator 3 (NCOA3; SRC3; AIB1)

Cancer

INDICATION: Breast cancer; cancer

In vitro testing, cell culture and mouse studies identified a small molecule inhibitor

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE